MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines

  • Lynne T. Bemis
  • , Robert Chen
  • , Carol M. Amato
  • , Elizabeth H. Classen
  • , Steven E. Robinson
  • , David G. Coffey
  • , Paul F. Erickson
  • , Yiqun G. Shellman
  • , William A. Robinson

Research output: Contribution to journalArticlepeer-review

Abstract

Micropthalmia-associated transcription factor (MITF) is the master regulator of melanocyte development, survival, and function. Frequent alteration in the expression of MITF is detected in melanoma, but the mechanism(s) underlying the alteration in expression have not been completely determined. In these studies, we have identified microRNA-137 (miR-137) as a regulator of MITF expression. The genomic locus of miR-137 at chromosome 1p22 places it in a region of the human genome previously determined to harbor an allele for melanoma susceptibility. Here, we show that expression of mature miR-137 in melanoma cell lines down-regulates MITF expression. Further, we have identified a 15-bp variable nucleotide tandem repeat located just 5′ to the pre-miR-137 sequence, which alters the processing and function of miR-137 in melanoma cell lines.

Original languageEnglish (US)
Pages (from-to)1362-1368
Number of pages7
JournalCancer Research
Volume68
Issue number5
DOIs
StatePublished - Mar 1 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines'. Together they form a unique fingerprint.

Cite this